Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Five Prime Therapeutics Inc

+ Add to Watchlist

FPRX:US

25.7400 USD 1.6100 5.89%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Five Prime Therapeutics Inc (FPRX)

Open: 27.4700 Day's Range: 25.4100 - 27.8100 Volume: 165,512
Previous Close: 27.3500 52wk Range: 10.5000 - 28.4700 1-Yr Rtn: +84.38%

Stock Chart for FPRX

No chart data available.
  • FPRX:US 25.7400
  • 1D
  • 1M
  • 1Y
27.3500
Interactive FPRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FPRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5903
Est. EPS (USD) (12/2014) -1.6100
Est. PEG Ratio -
Market Cap (M USD) 653.30
Shares Outstanding (M) 25.38
30 Day Average Volume 282,370
Price/Book (mrq) 5.8476
Price/Sale (ttm) 27.7782
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FPRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FPRX

Five Prime Therapeutics, Inc. provides clinical stage biotechnology services. The Company offers innovative protein and antibody therapeutics, as well as offers drugs for oncology and immunology diseases. FivePrime Therapeutics conducts serves customers in the United States.

Lewis T Williams "Rusty"President/CEO/Co-FounderMarc L BelskySenior VP/CFO
Julie HambletonSenior VP/Chief Medical OfcrAron M KnickerbockerSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for FPRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil